[Matrix metalloproteinases in inflammatory bowel disease - from basic research to clinical significance]

T Rath1, M Roderfeld, J Graf

  • 1Zentrum für Innere Medizin, Gastroenterologie, Justus-Liebig-Universität Giessen, 35385 Giessen.

Zeitschrift Fur Gastroenterologie
|August 8, 2009
PubMed

Insights

Matrix Metalloproteinases (MMPs) are key enzymes in extracellular matrix remodeling and inflammation. This review highlights their crucial roles in inflammatory bowel disease (IBD) pathophysiology and potential therapeutic targeting.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Gastroenterology

Background:

  • Matrix Metalloproteinases (MMPs) are zinc-dependent endopeptidases crucial for extracellular matrix (ECM) turnover.
  • MMPs regulate diverse non-matrix substrates, influencing cellular signaling and inflammatory processes.
  • These enzymes play significant roles in physiological processes like wound healing and pathological conditions including inflammatory bowel disease (IBD).

Purpose of the Study:

  • To summarize the multifaceted activities of MMPs in the context of IBD.
  • To emphasize the pathophysiological relevance of MMPs in intestinal inflammation.
  • To explore the potential clinical implications of MMP expression and regulation in IBD.

Main Methods:

  • Literature review focusing on MMPs in IBD.
  • Analysis of MMP expression and regulation patterns.
  • Synthesis of current understanding of MMP functions in the healthy and inflamed intestine.

Main Results:

  • MMPs are implicated in mucosal destruction and other pathophysiological aspects of IBD.
  • Beyond ECM degradation, MMPs modulate chemokines, cytokines, and growth factors relevant to IBD.
  • Emerging evidence points to novel functions of MMPs in both healthy and inflamed intestinal states.

Conclusions:

  • MMPs are central players in the pathophysiology of inflammatory bowel disease.
  • Understanding MMP regulation offers potential avenues for novel therapeutic strategies in IBD.
  • Further research into MMP activities is warranted for clinical applications in IBD management.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...